PHARMACOPEIA INC 4
4 · PHARMACOPEIA INC · Filed Dec 24, 2008
Insider Transaction Report
Form 4
PHARMACOPEIA INCPCOP
MOLLICA JOSEPH A
Director
Transactions
- Disposition to Issuer
Common Stock
2008-12-23−141,977.07→ 0 total
Footnotes (1)
- [F1]Disposed of pursuant to merger agreement between Pharmacopeia, Inc. ("Pharmacopeia"), Ligand Pharmaceuticals Incorporated ("Ligand") , Margaux Acquisition Corp., a wholly-owned subsidiary of Ligand, and Latour Acquisition, LLC, a wholly-owned subsidiary of Ligand, in exchange for approximately 84,973.28 shares of Ligand common stock having a market value of $2.58 per share on the effective date of the merger and $44,012.89 in cash, without interest. In addition, the reporting person received one contingent value right ("CVR") for each share of the Pharmacopeia common stock disposed of in the merger by the reporting person. The CVRs provide each holder the right to receive approximately $0.50 per share if Ligand enters into a license, sale, development, marketing or option agreement with respect to certain product candidates (other than any agreement with Bristol-Myers Squibb Company or any of its affiliates) on or prior to December 31, 2011.